It is reported that the oxidation of aldophamide could be accomplished directly by ALDH1, and downregulation of ALDH1 by antisense RNA could result in increasing the sensitivity of tumour cells to 4-hydroperoxy-cyclophosphamide (4-HC), an active derivative of cyclophosphamide [5]. Here, ALDH1A1 is linked to neoplasm.